<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00964470</url>
  </required_header>
  <id_info>
    <org_study_id>#AW-101008MC-DS</org_study_id>
    <nct_id>NCT00964470</nct_id>
  </id_info>
  <brief_title>Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery</brief_title>
  <acronym>AWBAT-D</acronym>
  <official_title>Multi-Center, Prospective, Randomized, Comparison of AWBAT™-D vs. Xeroform™ or Glucan II™ for Treatment of Donor Sites in Burn Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aubrey Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aubrey Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the rate of healing and the non-adherence of three
      types of dressings. The study will also compare rate of infection, scarring and perception of
      pain associated with treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate AWBAT™-D compared to Xeroform™ or Glucan II™ for the
      treatment of donor sites in burn surgery.

      Primary Study Goals:

        -  To compare the rate of healing of donor sites.

        -  To compare patient reported perception of pain

        -  To compare the potential clinical complication rates of:

             -  non-adherence,

             -  seroma

             -  hematoma

             -  infection

      Secondary Study Goal:

      • To compare clinical outcome of donor sites: scarring based on the Vancouver Scar Scale.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2009</start_date>
  <primary_completion_date type="Anticipated">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>• To compare the rate of healing of donor sites. • To compare patient reported perception of pain • To compare the potential clinical complication rates of: o non-adherence, o seroma o hematoma o infection</measure>
    <time_frame>2 year follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>• To compare clinical outcome of donor sites: scarring based on the Vancouver Scar Scale.</measure>
    <time_frame>2 year follow-up</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Treatment of Donor Site Burns</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AWBAT™-D and XEROFORM™ OR GLUCAN II™ dressings</intervention_name>
    <description>Dressing, donor site dressings</description>
    <other_name>AWBAT™-D and XEROFORM™ OR GLUCAN II™ donor site dressings</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Burn wounds measuring 1% - 30% TBSA requiring skin grafting

          -  Anterior bilateral donor sites of approximately the same size taken from the thighs or
             abdomen

        Exclusion Criteria:

          -  Ventilator dependence

          -  Pregnancy /Lactation

          -  Mechanism of injury was electrical, chemical or frostbite

          -  Co-morbidity which may compromise healing

          -  Known allergy to porcine or porcine products
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Steven Moss</last_name>
    <phone>760-602-8300</phone>
    <email>smoss@aubreyinc.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tara Cordova</last_name>
    <phone>760-602-8300</phone>
    <email>tcordova@aubreyinc.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wishard Health Services Burn Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajiv Sood, MD</last_name>
      <phone>317-278-1022</phone>
      <email>rsood@iupui.edu</email>
    </contact>
    <investigator>
      <last_name>Rajiv Sood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University Hospital Burn Center Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J. Kevin Bailey, MD</last_name>
      <phone>513-558-4361</phone>
      <email>baileyj4@ucmail.uc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rich Branson, MD</last_name>
      <phone>513-558-6785</phone>
      <email>richard.branson@uc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Firefighter's Regional Burn Center</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Hickerson, MD</last_name>
      <phone>901-448-2579</phone>
      <email>bhickerson@mac.com</email>
    </contact>
    <contact_backup>
      <last_name>Lisa K Mason-Sutton, BSN</last_name>
      <phone>901-448-2525</phone>
      <email>lmasonsu@utmem.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2009</study_first_submitted>
  <study_first_submitted_qc>August 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 25, 2009</study_first_posted>
  <last_update_submitted>June 21, 2010</last_update_submitted>
  <last_update_submitted_qc>June 21, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Stephen Moss/President</name_title>
    <organization>Aubrey Inc.</organization>
  </responsible_party>
  <keyword>Burn, donor site, skin graft, dressing, AWBAT™-D, XEROFORM™, GLUCAN II™</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

